[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PT65719A - Procede pour la preparation de nouvelles preparations galeniques - Google Patents

Procede pour la preparation de nouvelles preparations galeniques

Info

Publication number
PT65719A
PT65719A PT65719A PT6571976A PT65719A PT 65719 A PT65719 A PT 65719A PT 65719 A PT65719 A PT 65719A PT 6571976 A PT6571976 A PT 6571976A PT 65719 A PT65719 A PT 65719A
Authority
PT
Portugal
Prior art keywords
preparation
galenic preparations
new galenic
new
preparations
Prior art date
Application number
PT65719A
Other languages
English (en)
Portuguese (pt)
Other versions
PT65719B (fr
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of PT65719A publication Critical patent/PT65719A/fr
Publication of PT65719B publication Critical patent/PT65719B/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/48Ergoline derivatives, e.g. lysergic acid, ergotamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT65719A 1975-10-17 1976-10-15 Procede pour la preparation de nouvelles preparations galeniques PT65719B (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2546577A DE2546577B2 (de) 1975-10-17 1975-10-17 Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden

Publications (2)

Publication Number Publication Date
PT65719A true PT65719A (fr) 1976-11-01
PT65719B PT65719B (fr) 1978-06-12

Family

ID=5959411

Family Applications (1)

Application Number Title Priority Date Filing Date
PT65719A PT65719B (fr) 1975-10-17 1976-10-15 Procede pour la preparation de nouvelles preparations galeniques

Country Status (28)

Country Link
JP (1) JPS5854122B2 (fr)
AT (1) AT362510B (fr)
AU (1) AU508628B2 (fr)
BE (1) BE847368A (fr)
CA (1) CA1079641A (fr)
CH (1) CH643737A5 (fr)
CS (1) CS199647B2 (fr)
DE (1) DE2546577B2 (fr)
DK (1) DK146194C (fr)
ES (1) ES452420A1 (fr)
FI (1) FI762875A (fr)
FR (1) FR2327764A1 (fr)
GB (1) GB1560406A (fr)
GR (1) GR61268B (fr)
HK (1) HK3183A (fr)
HU (1) HU172533B (fr)
IE (1) IE43778B1 (fr)
IL (1) IL50686A (fr)
MY (1) MY8400063A (fr)
NL (1) NL184558C (fr)
NO (1) NO144468C (fr)
NZ (1) NZ182341A (fr)
PH (1) PH14513A (fr)
PT (1) PT65719B (fr)
SE (1) SE430379B (fr)
SG (1) SG63082G (fr)
SU (1) SU1165223A3 (fr)
ZA (1) ZA766166B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1572226A (en) * 1977-11-03 1980-07-30 Hoechst Uk Ltd Pharmaceutical preparations in solid unit dosage form
US4411882A (en) 1978-12-21 1983-10-25 Sandoz Ltd. Galenical compositions
CH642259A5 (de) * 1978-12-21 1984-04-13 Sandoz Ag Galenische zubereitungen fuer orale applikation von ergotalkaloiden.
FR2454804B1 (fr) * 1979-04-26 1986-11-21 Sanofi Sa Medicament a base de dihydroergotoxine et son procede de preparation
US4366145A (en) * 1981-06-24 1982-12-28 Sandoz, Inc. Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation
US4898729A (en) * 1983-12-09 1990-02-06 Euroceltique, S.A. Treatment of hypertension, compounds and compositions for antihypertension and diuresis
NL194389C (nl) * 1984-06-14 2002-03-04 Novartis Ag Werkwijze voor het bereiden van een vaste dispersie van een farmaceutisch actief middel dat een lage oplosbaarheid in water heeft, in een vaste matrix van een in water oplosbaar polyalkyleenglycol als drager.
ES2039287T3 (es) * 1987-01-14 1993-09-16 Ciba-Geigy Ag Procedimiento para la obtencion de un sistema terapeutico peroral para productos activos dificilmente solubles.
FR2610827B1 (fr) * 1987-02-18 1991-09-13 Pf Medicament Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication
US5064656A (en) * 1989-11-14 1991-11-12 Dr. Gergely & Co. Uncoated pharmaceutical reaction tablet
DE4401646A1 (de) * 1994-01-21 1995-07-27 Krewel Werke Gmbh Optimal freisetzende Kava-Extrakte
US6524832B1 (en) 1994-02-04 2003-02-25 Arch Development Corporation DNA damaging agents in combination with tyrosine kinase inhibitors
US6632455B2 (en) 1997-12-22 2003-10-14 Schering Corporation Molecular dispersion composition with enhanced bioavailability
ATE260105T1 (de) * 1997-12-22 2004-03-15 Schering Corp Zubereitung enthaltend eine molekulardispersion mit erhöhter bioverfügbarkeit
US6316462B1 (en) 1999-04-09 2001-11-13 Schering Corporation Methods of inducing cancer cell death and tumor regression
CA2393344C (fr) * 1999-12-03 2009-09-01 Polichem S.A. Procedes permettant la preparation de compositions pharmaceutiques a liberation prolongee d'alcaloides d'ergot presentant une biodisponibilite amelioree et compositions ainsi obtenues
US7771746B2 (en) 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
US7135436B2 (en) 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
PT1638527E (pt) * 2003-06-27 2007-02-28 Bioprogress Spa Produto compósito obtido por co-trituração de um princípio activo com um copolímero de n-vinil-2-pirrolidona/acetato de vinilo
WO2016198983A1 (fr) 2015-06-09 2016-12-15 Bend Research Inc. Formulations pour obtenir une dissolution rapide d'un médicament à partir de dispersions séchées par pulvérisation dans des capsules

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1175430A (en) * 1966-04-07 1969-12-23 Sandoz Ltd Pharmaceutical Compositions containing Ergot Alkaloids

Also Published As

Publication number Publication date
GB1560406A (en) 1980-02-06
CA1079641A (fr) 1980-06-17
HK3183A (en) 1983-01-20
FI762875A (fr) 1977-04-18
FR2327764A1 (fr) 1977-05-13
NO144468C (no) 1981-09-09
DK454176A (da) 1977-04-18
PT65719B (fr) 1978-06-12
IE43778B1 (en) 1981-05-20
DE2546577A1 (de) 1977-04-21
HU172533B (hu) 1978-09-28
PH14513A (en) 1981-08-24
SU1165223A3 (ru) 1985-06-30
SE430379B (sv) 1983-11-14
MY8400063A (en) 1984-12-31
NZ182341A (en) 1978-09-20
AU1875476A (en) 1978-04-20
IL50686A (en) 1979-05-31
JPS5251014A (en) 1977-04-23
DK146194B (da) 1983-07-25
CH643737A5 (en) 1984-06-29
NO144468B (no) 1981-06-01
NL184558B (nl) 1989-04-03
BE847368A (fr) 1977-04-15
IE43778L (en) 1977-04-17
ATA767976A (de) 1980-10-15
GR61268B (en) 1978-10-17
NO763446L (fr) 1977-04-19
SE7611189L (sv) 1977-04-18
NL7611295A (nl) 1977-04-19
JPS5854122B2 (ja) 1983-12-02
CS199647B2 (en) 1980-07-31
ZA766166B (en) 1978-05-30
SG63082G (en) 1983-09-09
ES452420A1 (es) 1978-04-16
DE2546577B2 (de) 1981-04-02
NL184558C (nl) 1989-09-01
DK146194C (da) 1984-01-02
AU508628B2 (en) 1980-03-27
IL50686A0 (en) 1976-12-31
FR2327764B1 (fr) 1979-03-02
AT362510B (de) 1981-05-25

Similar Documents

Publication Publication Date Title
FR2325668A1 (fr) Procede pour la preparation de polyurethannes
RO74936A (fr) Procede pour la preparation des mercaptoazetidiones
PT65719A (fr) Procede pour la preparation de nouvelles preparations galeniques
BE838754A (fr) Procede ameliore pour la preparation de dimethylol-2, 2-alcanals
PT65388B (fr) Procede pour la preparation de peptides
RO69608A (fr) Procede pour la preparation des 1,2-benzisothiazole-3-ones
FR2307827A1 (fr) Procede pour la preparation d'oligomeres d'hexafluoropropene
BE838823A (fr) Procede pour la preparation de 1,2,5-dihydroxycholecalciferol
FR2303541A1 (fr) Procede de preparation de nouvelles indolylalcoylpiperidines
RO72547A (fr) Procede pour la preparation des esters 2',3,6'-trichlore-4-cyan-4'-benzoylureidodiphenyliques
FR2335522A1 (fr) Procede de preparation d'androstene-4 diones-3,17
BE842584A (fr) Procede pour la preparation de dihalogenures gemines
RO70079A (fr) Procede pour la preparation des n-aryle-n-(4-pyperidinyle)-arylacetamides
FR2314192A1 (fr) Procede de preparation d'oxaphospholannes-1,2
PT64718B (fr) Procede pour la preparation de phenyalcoylamines
RO76667A (fr) Procede pour la preparation des 2,4-dialkyamino-6-chlore-5-triazines
BE845327A (fr) Procede de preparation de 4,4'-dihydroxy-3-3'-5-5'-tretralcoyldiphenylalcanes
RO72558A (fr) Procede pour la preparation des cycloalcanpyrazoles
RO70232A (fr) Procede pour la preparation des 4-pyrazolile-4h-1,2,4-triazolile
PT64691B (fr) Procede pour la preparation d'acides 6,11-di-hydro-11-oxo-dibenz /b,e/ oxepin-alcanoiques
FR2317290A1 (fr) Procede pour la preparation de 5-cyanopyridones-(6)
FR2348174A1 (fr) Procede pour la preparation de dihalogenures gemines
FR2296628A1 (fr) Procede pour la preparation de chloroamino-s-triazines
FR2331565A1 (fr) Procede pour la preparation de triarylborane
FR2313336A2 (fr) Procede pour la preparation de cycloalcanones et cycloalcanols